Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02598752 · ClinicalTrials.gov registry record
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 11
- Enrollment target
NCT02598752: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02598752 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02598752 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to see if exercise fitness testing is feasible and safe in persons over 21 years of age who have been diagnosed with a hematological malignancy and are scheduled to undergo a hematopoietic stem cell transplant (HCT). Assessments in this study will look at the capacity of the body before transplantation to see if these measures can help predict how patients do after transplant.
Primary Outcome
is a measure determined by the CPET
Interventions
- OTHER Symptom-limited cardiopulmonary exercise test (CPET)
- OTHER Resting assessment of cardiac function by echocardiography
- OTHER Post-exercise assessment of cardiac function by echocardiography
- OTHER Pulmonary function
- BEHAVIORAL Patient-reported outcomes questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-11 |
| Est. Completion | 2020-04-10 |
What the finished NCT02598752 record still lists
NCT02598752 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Symptom-limited cardiopulmonary exercise test (CPET) is the first listed.
NCT02598752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02598752 about?
NCT02598752 is a clinical study titled "Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation". The purpose of this study is to see if exercise fitness testing is feasible and safe in persons over 21 years of age who have been diagnosed with a hematological malignancy and are scheduled to undergo a hematopoietic stem cell transplant (HCT). Assessments in this study will look at the capacity of...
What is the current status of trial NCT02598752?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2015-11. Estimated completion is 2020-04-10.
What interventions are being tested in trial NCT02598752?
The interventions under investigation include: Symptom-limited cardiopulmonary exercise test (CPET) (OTHER), Resting assessment of cardiac function by echocardiography (OTHER), Post-exercise assessment of cardiac function by echocardiography (OTHER), Pulmonary function (OTHER), Patient-reported outcomes questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02598752?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia